Arrowhead Pharmaceuticals (ARWR) Earnings Date, Estimates & Call Transcripts $16.06 -0.76 (-4.52%) Closing price 04:00 PM EasternExtended Trading$16.02 -0.04 (-0.22%) As of 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Arrowhead Pharmaceuticals Earnings Summary Arrowhead Pharmaceuticals posted Q2 2025 earnings on May 12, 2025, reporting an EPS of $2.75, which beat the consensus estimate of -$0.06 by $2.81. Quarterly revenue was reported to be $542.71 million, above analysts' expectations of $116.27 million. With a trailing EPS of -$1.40, Arrowhead Pharmaceuticals' earnings are expected to decrease next year, from ($2.42) to ($3.16) per share. Upcoming Q3 Earnings DateAug. 14After Market ClosesEstimatedConsensus EPS (May. 12) -$0.06 Actual EPS (May. 12) $2.75 Beat By $2.81 Actual Revenue (May. 12) $542.71MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)ARWR Upcoming EarningsArrowhead Pharmaceuticals' next earnings date is estimated for Thursday, August 14, 2025, based on past reporting schedules. Powered by Get Arrowhead Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arrowhead Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataARWR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ARWR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Arrowhead Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$1.07-$1.07-$1.07Q2 20254-$1.01$2.66$0.18Q3 20254-$1.24-$0.29-$0.94Q4 20254-$1.00$1.05$0.33 Arrowhead Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/14/2025(Estimated)--------5/12/2025Q2 2025-$0.06$2.75+$2.81$2.75$116.27M$542.71M2/10/2025Q1 2025-$0.42-$1.39 -$0.97-$1.39$19.05M-8/8/2024Q3 2024-$0.58-$1.38 -$0.80-$1.38$52.87M-5/9/2024Q2 2024-$0.06-$1.02 -$0.96-$1.02$41.97M-2/6/2024Q1 2024-$0.78-$1.24 -$0.46-$1.24$35.60M$3.55M11/29/2023Q4 2023-$0.70-$1.03 -$0.33-$1.03$38.87M$16.10M8/7/2023Q3 2023-$0.58-$0.96 -$0.38-$0.96$45.42M$15.83M Arrowhead Pharmaceuticals Earnings - Frequently Asked Questions When is Arrowhead Pharmaceuticals's earnings date? Arrowhead Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on ARWR's earnings history. Did Arrowhead Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported $2.75 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.06) by $2.81. Learn more on analysts' earnings estimate vs. ARWR's actual earnings. How can I listen to Arrowhead Pharmaceuticals's earnings conference call? The conference call for Arrowhead Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Arrowhead Pharmaceuticals's conference call transcript? The conference call transcript for Arrowhead Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Arrowhead Pharmaceuticals generate each year? Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded annual revenue of $545.21 million. How much profit does Arrowhead Pharmaceuticals generate each year? Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded net income of -$599.49 million. ARWR has generated -$1.40 earnings per share over the last four quarters. What is Arrowhead Pharmaceuticals's EPS forecast for next year? Arrowhead Pharmaceuticals's earnings are expected to decrease from ($2.42) per share to ($3.16) per share in the next year. More Earnings Resources from MarketBeat Related Companies ROIV Earnings Results RVMD Earnings Results BPMC Earnings Results BBIO Earnings Results ELAN Earnings Results VRNA Earnings Results GRFS Earnings Results TGTX Earnings Results LEGN Earnings Results NUVL Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles e.l.f. Beauty Sees Record Surge After Earnings, Rhode DealCrowdStrike Stock Slips: Analyst Downgrades Before Earnings Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the Stock This page (NASDAQ:ARWR) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThe Social Security Changes No One’s Talking AboutWhile most Americans worry about their next Social Security check... something far bigger is happening behind ...Altimetry | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrowhead Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARWR Stock Free ARWR Stock Alerts